Programmed death ligand-1 over-expression correlates with malignancy and contributes to immune regulation in ovarian cancer

Christian J. Maine(Scripps Research Institute), Sadaf Ghaem‐Maghami(Hammersmith Hospital), Lynsey M. Whilding(Hammersmith Hospital), Nor Haslinda Abd Aziz(National University of Malaysia), Jayanta Chatterjee(Indian Institute of Science Bangalore), Nancy Brewig(Hammersmith Hospital), Claudia Hayford(Hammersmith Hospital), Andrew J.T. George(Moorfields Eye Hospital NHS Foundation Trust)
Cancer Immunology Immunotherapy
December 2, 2013
Cited by 126


Related Papers